Behavioral, biochemical and cellular correlates in the protective effect of sertraline against transient global ischemia induced behavioral despair: Possible involvement of nitric oxide-cyclic guanosine monophosphate study pathway

Brain Research Bulletin

Volumn 82, Issue 1-2, 2010, Pages 57-64

  Gaur, Vaibhav ^a   Kumar, Anil ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Antidepressants; Ischemia; Mitochondrial dysfunction; Oxidative stress; Post stroke depression; Sertraline

Indexed keywords

7 NITROINDAZOLE; ARGININE; CYCLIC GMP; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SERTRALINE; SILDENAFIL; SUCCINATE DEHYDROGENASE (UBIQUINONE); UBIQUINOL CYTOCHROME C REDUCTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CHEMICAL ANALYSIS; COMMON CAROTID ARTERY; CONTROLLED STUDY; DEPRESSION; DRUG ANTAGONISM; DRUG POTENTIATION; ENZYME ACTIVITY; IMMOBILIZATION; LOW DRUG DOSE; MOLECULAR MECHANICS; MONOTHERAPY; MOUSE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REPERFUSION INJURY; SHAM PROCEDURE; SIGNAL TRANSDUCTION;

ADULT; ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; CELL RESPIRATION; CYCLIC GMP; DEPRESSION; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MICE; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; NEUROPSYCHOLOGICAL TESTS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONORS; OXIDATIVE STRESS; RANDOM ALLOCATION; REPERFUSION INJURY; SERTRALINE;

EID: 77952319967     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2010.01.010     Document Type: Article

References (50)

1. Alcaro A., Cabib S., Ventura R., Puglisi-Allegra S. Genotype- and experience-dependent susceptibility to depressive-like responses in the forced-swimming test. Psychopharmacology (Berl) 2002, 164:138-143.
2. Almeida A., Allen K.L., Bates T.E., Clark J.B. Effect of reperfusion following cerebral ischaemia on the activity of the mitochondrial respiratory chain in the gerbil brain. J. Neurochem. 1995, 65:1698-1703.
3. Bederson J.B., Pitts L.H., Tsuji M., Nishimura M.C., Davis R.L., Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 1986, 17:472-476.
4. Bender A.T., Beavo J.A. Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol. Rev. 2006, 58:488.
5. Berg A., Lonnqvist J., Palomaki H., Kaste M. Assessment of depression after stroke: a comparison of different screening instruments. Stroke 2009, 40:523-529.
6. Berman S.B., Hastings T.G. Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease. J. Neurochem. 1999, 73:1127-1137.
7. Borsini F. Role of the serotonergic system in the forced swimming test. Neurosci. Biobehav. Rev. 1995, 19:377-395.
8. Brown G.C. Nitric oxide inhibition of cytochrome oxidase and mitochondrial respiration: implications for inflammatory, neurodegenerative and ischaemic pathologies. Mol. Cell Biochem. 1997, 174:189-192.
9. Cramer S.C. Repairing the human brain after stroke: I. Mechanisms of spontaneous recovery. Ann. Neurol. 2008, 63:272-287.
10. Cryan J.F., Page M.E., Lucki I. Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test. Eur. J. Pharmacol. 2002, 436:197-205.
11. Denninger J.W., Marletta M.A. Guanylate cyclase and the NO/cGMP signaling pathway. BBA-Bioenergetics 1999, 1411:334-350.
12. Dhir A., Kulkarni S.K. Involvement of l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of venlafaxine in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry 2007, 31:921-925.
13. Duan W., Peng Q., Masuda N., Ford E., Tryggestad E., Ladenheim B., Zhao M., Cadet J.L., Wong J., Ross C.A. Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease. Neurobiol. Dis. 2008, 30:312-322.
14. Durukan A., Tatlisumak T. Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol. Biochem. Behav. 2007, 87:179-197.
15. Ellman G.L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 1959, 82:70-77.
16. Gaur V., Aggarwal A., Kumar A. Protective effect of naringin against ischemic reperfusion cerebral injury: possible neurobehavioral, biochemical and cellular alterations in rat brain. Eur. J. Pharmacol. 2009, 616:147-154.
17. Gornall A.G., Bardawill C.J., David M.M. Determination of serum proteins by means of the biuret reaction. J. Biol. Chem. 1949, 177:751-766.
18. Green A.R. Pharmacological approaches to acute ischaemic stroke: reperfusion certainly, neuroprotection possibly. Br. J. Pharmacol. 2008, 153(Suppl. 1):S325-S338.
19. Green L.C., Wagner D.A., Glogowski J., Skipper P.L., Wishnok J.S., Tannenbaum S.R. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem. 1982, 126:131-138.
20. Gupta Y.K., Sinha K., Chaudhary G., Jagannathan N.R. Protective effect of adenosine against neuronal injury induced by middle cerebral artery occlusion in rats as evidenced by diffusion-weighted imaging. Pharmacol. Biochem. Behav. 2002, 72:569-574.
21. Harkin A., Connor T.J., Burns M.P., Kelly J.P. Nitric oxide synthase inhibitors augment the effects of serotonin re-uptake inhibitors in the forced swimming test. Eur. Neuropsychopharmacol. 2004, 14:274-281.
22. Kelly S., McCulloch J., Horsburgh K. Minimal ischaemic neuronal damage and HSP70 expression in MF1 strain mice following bilateral common carotid artery occlusion. Brain Res. 2001, 914:185-195.
23. King T.E. Preparation of succinate dehydrogenase and reconstitution of succinate oxidase. Methods Enzymol. 1967, 10:322-331.
24. King T.E., Howard R.L. Preparation and properties of soluble NADH dehydrogenase from cardiac muscle. Methods Enzymol. 1967, 10:275-294.
25. Kono Y. Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch Biochem. Biophys. 1978, 186:189-195.
26. Kulkarni S.K., Mehta A.K. Purine nucleoside-mediated immobility in mice: reversal by antidepressants. Psychopharmacology (Berl) 1985, 85:460-463.
27. Kumar A., Garg R., Kumar P. Nitric oxide modulation mediates the protective effect of trazodone in a mouse model of chronic fatigue syndrome. Pharmacol. Rep. 2008, 60:664-672.
28. Kumar P., Kumar A. Possible role of sertraline against 3-nitropropionic acid induced behavioral, oxidative stress and mitochondrial dysfunctions in rat brain. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33:100-108.
29. Kumar P., Padi S.S., Naidu P.S., Kumar A. Possible neuroprotective mechanisms of curcumin in attenuating 3-nitropropionic acid-induced neurotoxicity. Methods Find Exp. Clin. Pharmacol. 2007, 29:19-25.
30. Liu Y., Peterson D.A., Kimura H., Schubert D. Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction. J. Neurochem. 1997, 69:581.
31. Luck H. Catalase, methods of enzymatic analysis. Methods of Enzymatic Analysis 1971, 885-893. Academic Press, New York. H.U. Bergmeyer (Ed.).
32. Lucki I. The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav. Pharmacol. 1997, 8:523-532.
33. Maher P. The effects of stress and aging on glutathione metabolism. Ageing Res. Rev. 2005, 4:288-314.
34. Nakai A. Role of mitochondrial permeability transition in the immature brain following intrauterine ischemia. J. Nippon Med. School 2007, 74:190-201.
35. Petit-Demouliere B., Chenu F., Bourin M. Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology (Berl) 2005, 177:245-255.
36. Porsolt R.D., Le Pichon M., Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977, 266:730-732.
37. Schmidt-Kastner R., Truettner J., Lin B., Zhao W., Saul I., Busto R., Ginsberg M.D. Transient changes of brain-derived neurotrophic factor (BDNF) mRNA expression in hippocampus during moderate ischemia induced by chronic bilateral common carotid artery occlusions in the rat. Brain Res. Mol. Brain Res. 2001, 92:157-166.
38. Seligman M.E. Learned helplessness as a model of depression. Comment and integration. J. Abnorm. Psychol. 1978, 87:165-179.
39. Sims N.R., Zaidan E. Biochemical changes associated with selective neuronal death following short-term cerebral ischaemia. Int. J. Biochem. Cell Biol. 1995, 27:531-550.
40. Sottocasa G.L., Kuylenstierna B., Ernster L., Bergstrand A. An electron-transport system associated with the outer membrane of liver mitochondria. A biochemical and morphological study. J. Cell Biol. 1967, 32:415-438.
41. Steru L., Chermat R., Thierry B., Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 1985, 85:367-370.
42. Tharwani H.M., Yerramsetty P., Mannelli P., Patkar A., Masand P. Recent advances in poststroke depression. Curr. Psychiatry Rep. 2007, 9:225-231.
43. Wei G., Kibler K.K., Koehler R.C., Maruyama T., Narumiya S., Dore S. Prostacyclin receptor deletion aggravates hippocampal neuronal loss after bilateral common carotid artery occlusion in mouse. Neuroscience 2008, 156:1111-1117.
44. Wills E.D. Mechanisms of lipid peroxide formation in animal tissues. Biochem. J. 1966, 99:667-676.
45. Wong E.H., Sonders M.S., Amara S.G., Tinholt P.M., Piercey M.F., Hoffmann W.P., Hyslop D.K., Franklin S., Porsolt R.D., Bonsignori A., Carfagna N., McArthur R.A. Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor. Biol. Psychiatry 2000, 47:818-829.
46. Yan B., He J., Xu H., Zhang Y., Bi X., Thakur S., Gendron A., Kong J., Li X.M. Quetiapine attenuates the depressive and anxiolytic-like behavioural changes induced by global cerebral ischemia in mice. Behav. Brain Res. 2007, 182:36-41.
47. Yan B., Wang D.Y., Xing D.M., Ding Y., Wang R.F., Lei F., Du L.J. The antidepressant effect of ethanol extract of radix puerariae in mice exposed to cerebral ischemia reperfusion. Pharmacol. Biochem. Behav. 2004, 78:319-325.
48. Yanpallewar S.U., Rai S., Kumar M., Acharya S.B. Evaluation of antioxidant and neuroprotective effect of Ocimum sanctum on transient cerebral ischemia and long-term cerebral hypoperfusion. Pharmacol. Biochem. Behav. 2004, 79:155-164.
49. Yanpallewar S., Rai S., Kumar M., Chauhan S., Acharya S.B. Neuroprotective effect of Azadirachta indica on cerebral post-ischemic reperfusion and hypoperfusion in rats. Life Sci. 2005, 76:1325-1338.
50. Zahler W.L., Cleland W.W. A specific and sensitive assay for disulfides. J. Biol. Chem. 1968, 243:716-719.